Double-blind controlled trial of topical acyclovir in genital herpes simplex virus infections. - Wikidata - wikimedia - TriplyDB

Double-blind controlled trial of topical acyclovir in genital herpes simplex virus infections.

Double-blind controlled trial of topical acyclovir in genital herpes simplex virus infections.

http://www.wikidata.org/entity/Q45793077

about

Predominance of herpes simplex virus type 1 from patients with genital herpes in Nova Scotia Chemotherapeutics Comparison of the vaginal microbial communities in women with recurrent genital HSV receiving acyclovir intravaginal rings.Effect of recombinant interferon alpha 2 on clinical course of first episode genital herpes infection and subsequent recurrences.Effect of acyclovir treatment of primary genital herpes on the antibody response to herpes simplex virus Progress in meeting today's demands in genital herpes: an overview of current management.Acyclovir prophylaxis for herpes simplex virus infection.Comparative activities of selected combinations of acyclovir, vidarabine, arabinosyl hypoxanthine, interferon, and polyriboinosinic acid-polyribocytidylic acid complex against herpes simplex virus type 2 in tissue culture and intravaginally inoculat Alteration of lymphocyte transformation response to herpes simplex virus infection by acyclovir therapy.Efficacy of 2'-nor-2'-deoxyguanosine treatment for orofacial herpes simplex virus type 1 skin infections in mice Safety and pharmacokinetics of aciclovir in women following release from a silicone elastomer vaginal ring.Chitosan and Kappa-Carrageenan Vaginal Acyclovir Formulations for Prevention of Genital Herpes. In Vitro and Ex Vivo Evaluation.Contemporary antiviral drug regimens for the prevention and treatment of orolabial and anogenital herpes simplex virus infection in the normal host: Four approved indications and 13 off-label uses.6-Deoxyacyclovir: a xanthine oxidase-activated prodrug of acyclovir.Topical Acyclovir for Recurrent Herpes Labialis in Primary Care: Critical appraisal Application and tolerability of Herpotherm(®) in the treatment of genital herpes.Herpes simplex virus and human papillomavirus genital infections: new and investigational therapeutic options.Interventions for men and women with their first episode of genital herpes.Evaluation of the activity and safety of CS21 barrier genital gel® compared to topical aciclovir and placebo in symptoms of genital herpes recurrences: a randomized clinical trial.ME-609: a treatment for recurrent herpes simplex virus infections.Antiviral chemotherapy in genital herpes simplex virus infections.Dermatology-important advances in clinical medicine: acyclovir and herpes simplex.Genivir (DIP-253) 1% cream versus placebo cream in the treatment of recurrent genital herpes: a double-blind study.Herpes Simplex Virus: Partner for Life.Vaginal Mucosa and Drug Delivery

P2860

Q24670332-B108F427-A1AF-40E5-9CB0-B33282BC954E Q30047670-883D6A1F-4D7C-4D50-B479-B54050F636FF Q33554048-A4FFCF5A-B481-4D72-893F-0CF712125016 Q33583092-773C99B4-F668-4BBC-94A8-47EC398B9608 Q34605155-69248144-1E03-48AF-B301-29BE150937A9 Q34918299-D0E0616C-A27D-4F1D-913C-A0419986D0C7 Q35537506-DB47D2E2-5B6C-468D-863E-3CC4E69AE046 Q35640110-C758B4CE-E254-4908-9267-699DC2FF21F3 Q35641161-02F83A8D-FA65-489B-87D3-4A0E310DC38B Q35756914-BD275345-7D2F-4232-90CF-2F4DA74A87C1 Q36088773-E75A6C9D-0EA0-4159-A1F7-A67933CA7410 Q36096590-E9FC3CFA-00E7-41AB-B248-C9D3FF985B7E Q36170672-72BC7C97-7EE7-4DF5-95BE-7264E4F2D817 Q36261735-C3FD5F5F-D966-44BF-BA1B-FA3AEC345661 Q36282949-6398DEBA-B3D0-493D-9930-ABF98AD5D745 Q36925485-108EB4C9-A212-4A56-A4A7-BFDDF4F7D7CC Q37771396-4B8972BA-7725-40E0-8EDE-061A3BF75BA2 Q38941189-72BA7E1E-67B9-408E-B2E7-C069ABF7F6CD Q39220986-3DB7F6DB-74B7-443E-9721-9C97E23112E5 Q40622196-9E417ED9-A73D-435B-B56A-8B2BD5C48B36 Q40938400-1E1C2870-0EC7-45D3-B62A-55AF4514AA12 Q41492715-FE21D90D-2A2D-4D08-8F18-E2A690B5CAD2 Q44784427-95577EDD-A79D-4B1C-A5D5-B30F7A492930 Q45865498-1E2E8C1C-B2D4-477F-A2EE-D5E01529697C Q57570821-E8562EFE-FF7A-4E2D-834B-3FCF98F95F51

P2860

Double-blind controlled trial of topical acyclovir in genital herpes simplex virus infections.

http://www.wikidata.org/entity/Q45793077

description

1982 nî lūn-bûn

@nan

1982年の論文

@ja

1982年学术文章

@wuu

1982年学术文章

@zh-cn

1982年学术文章

@zh-hans

1982年学术文章

@zh-my

1982年学术文章

@zh-sg

1982年學術文章

@yue

1982年學術文章

@zh

1982年學術文章

@zh-hant

name

Double-blind controlled trial ...... rpes simplex virus infections.

@en

Double-blind controlled trial ...... rpes simplex virus infections.

@nl

type

label

Double-blind controlled trial ...... rpes simplex virus infections.

@en

Double-blind controlled trial ...... rpes simplex virus infections.

@nl

prefLabel

Double-blind controlled trial ...... rpes simplex virus infections.

@en

Double-blind controlled trial ...... rpes simplex virus infections.

@nl

P1433

Q45793077-11325D95-965E-4E07-B1C6-FC20B2D48751

P1476

Q45793077-597580A7-9B85-4EAA-9BEA-D2459C42DD7B

P2093

Q45793077-10A4D686-6337-4A14-801E-0D0DEE8909D2

Q45793077-1109F7E0-EA46-42BC-B833-6990F1E02B7E

Q45793077-16E9E9CA-63CD-4AC9-8C98-183F136A47B2

Q45793077-5F1944E5-1005-4B5C-BC7A-12EC138A21C0

Q45793077-79737319-F05B-451B-8294-2DE9304B1B42

Q45793077-8176FD0B-47A2-4901-9A5B-9A6FC6DD94A0

Q45793077-91C38BB4-A3F9-4567-9F59-5D094F0AB42D

Q45793077-9ADF5C3D-A789-419B-9998-A9C554F8A269

Q45793077-D30803C7-BD38-4B99-B3F6-EB544F5A5193

Q45793077-DFC56836-59F0-41CB-AB57-62165876CCD9

P304

Q45793077-444DE8A9-25DA-4C46-8D94-D1240B18406A

P31

Q45793077-F7A4CF64-044D-465E-BE11-1F4F7CF576AD

P356

Q45793077-9D5E1B18-0D55-4669-8742-F86B3EE07162

P407

Q45793077-0E19533E-1E23-4647-8432-166073A80A2C

P433

Q45793077-8F0BCD5E-176A-447E-A17B-55894B842820

P478

Q45793077-E7347B3D-4045-4937-AA5A-CCFDF14FDDB4

P577

Q45793077-7E1CF528-2195-4B5A-B9B3-3FBB844CD096

P698

Q45793077-2796C435-FE42-4922-9675-0483C30B2EA9

P356

0002-9343(82)90117-6

P1433

The American Journal of Medicine

P1476

Double-blind controlled trial ...... rpes simplex virus infections.

@en

P2093

A L Fahnlander

http://www.w3.org/2001/XMLSchema#string

C A Winter

http://www.w3.org/2001/XMLSchema#string

C W Critchlow

http://www.w3.org/2001/XMLSchema#string

D L Salter

http://www.w3.org/2001/XMLSchema#string

J D Connor

http://www.w3.org/2001/XMLSchema#string

J K Benedetti

http://www.w3.org/2001/XMLSchema#string

K K Holmes

http://www.w3.org/2001/XMLSchema#string

K Smith

http://www.w3.org/2001/XMLSchema#string

L Corey

http://www.w3.org/2001/XMLSchema#string

L G Davis

http://www.w3.org/2001/XMLSchema#string

P304

326-334

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/0002-9343(82)90117-6

http://www.w3.org/2001/XMLSchema#string

P407

P433

1A

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P577

1982-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

7048919

http://www.w3.org/2001/XMLSchema#string